During the past decade, Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Charite University, Berlin, Germany" with 2 trials sponsored, "Galderma R&D" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik" #1 collaborator was "BioNTech SE" with 1 trials as a collaborator, "Bioskin GmbH" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik" are "Chronic Urticaria" (2 trials), "Melanoma" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Advanced Melanoma" (1 trials) and "Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik" in a lesser frequency.

Most popular intervention types in "Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik" are "Drug" (8 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Cobimetinib" (2 trials), "Pembrolizumab" (2 trials), "Atezolizumab Placebo" (1 trials) and "Calcitriol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik has several departments that took part in Clinical trials: "Department of Dermatology, University of Mainz" - 2 trials, "Clinical research center (CRC), Department of Dermatology" - 2 trials